Priority Date: 14.12.11 (US 201161570405P)

NANOPARTICLES WITH ENHANCED MUCOSAL PENETRATION OR DECREASED INFLAMMATION

  • Application ID: EP12820997
  • Status: EXAMINATION IN PROGRESS

Applicant

Research organisation logo small
Research Organisation

Attorney

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Potter Clarkson LLP is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 14.12.2011 - Priority Date (US 201161570405P)
  • 20.06.2013 - Publication A2 (WO2013090804)
  • 22.10.2014 - Publication A2 (EP2790733)

IPC Classification